West Virginia, Mississippi, and Arkansas are the U.S. states with the highest percentage of their population who are obese. The states with the lowest percentage of their population who are obese include Colorado, Hawaii, and Massachusetts. Obesity in the United States Obesity is a growing problem in many countries around the world, but the United States has the highest rate of obesity among all OECD countries. The prevalence of obesity in the United States has risen steadily over the previous two decades, with no signs of declining. Obesity in the U.S. is more common among women than men, and overweight and obesity rates are higher among African Americans than any other race or ethnicity. Causes and health impacts Obesity is most commonly the result of a combination of poor diet, overeating, physical inactivity, and a genetic susceptibility. Obesity is associated with various negative health impacts, including an increased risk of cardiovascular diseases, certain types of cancer, and diabetes type 2. As of 2022, around 8.4 percent of the U.S. population had been diagnosed with diabetes. Diabetes is currently the eighth leading cause of death in the United States.

In 2022, over 33 percent of both men and women in the United States reported themselves as obese (BMI over 30), making it the country with the highest percentage of obese adults on this list. Other selected countries on the list with a high prevalence of obesity among adults included the United Kingdom and Australia. Obesity groups in the United States In 2022, Black adults had the highest overweight and obesity rates of any race or ethnicity in the United States. Asians and Native Hawaiians or Pacific Islanders had the lowest rates by far, with roughly 14 percent. In 2021, about 30 percent of people aged 65 and older were obese in the United States. This estimate has been steadily increasing since 2013 when roughly 27 percent of elderly Americans were obese. Leading health problems worldwide Obesity was considered one of 2023’s biggest health problems: 25 percent of adults worldwide stated that obesity was the biggest health issue for people within their country. Around 44 percent of adults stated that mental health was the most significant problem facing their country that year.

In 2019, it was estimated that around 8.5 percent of deaths worldwide could be attributed to obesity. The countries with the highest share of deaths that could be attributed to obesity included Fiji, the Cook Islands, and the United Arab Emirates. This statistic shows the countries with the highest share of deaths attributable to obesity worldwide in 2019.

United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data was reported at 6.900 % in 2012. This records an increase from the previous number of 6.400 % for 2009. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data is updated yearly, averaging 6.900 % from Dec 1991 (Median) to 2012, with 6 observations. The data reached an all-time high of 8.700 % in 2005 and a record low of 5.100 % in 1991. United States US: Prevalence of Overweight: Weight for Height: Female: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight, female, is the percentage of girls under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; World Health Organization, Global Database on Child Growth and Malnutrition. Country-level data are unadjusted data from national surveys, and thus may not be comparable across countries.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

In 2022, the U.S. states with the highest rates of obesity among women were Tennessee, Louisiana, and Mississippi. At that time, almost 43 percent of women in Tennessee were considered obese. The states with the highest rates of obesity among men are West Virginia, Kentucky, and Oklahoma. Obesity: Women vs. men As of 2022, women in the United States had slightly higher rates of obesity than men. At that time, around 34.1 percent of women were considered obese, compared to 32.6 percent of men. Rates of obesity among both men and women are higher in the United States than any other OECD country, with high-calorie diets, often from fast food and sugary drinks, and large food portion sizes being partly to blame. In 2023, the mean self-reported weight among men in the United States was 199 pounds, while women reported weighing an average of 164 pounds. Which state is the most obese? As of 2022, West Virginia had the highest prevalence of adult obesity in the United States, with around 41 percent of the population considered obese. Following West Virginia, Louisiana, Oklahoma, and Mississippi, had some of the highest rates of obesity in the country. Colorado had the lowest share of adults who were obese at that time, but still, a quarter of adults in the state were obese. West Virginia is also the state with the highest prevalence of obesity among high school students, with 27 percent of high schoolers considered obese in 2021. Obesity in childhood is associated with obesity as adults, as well as mental health problems such as anxiety and depression.

US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data was reported at 6.000 % in 2012. This records a decrease from the previous number of 7.800 % for 2009. US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data is updated yearly, averaging 7.000 % from Dec 1991 (Median) to 2012, with 5 observations. The data reached an all-time high of 8.100 % in 2005 and a record low of 5.400 % in 1991. US: Prevalence of Overweight: Weight for Height: % of Children Under 5 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's new child growth standards released in 2006.; ; UNICEF, WHO, World Bank: Joint child malnutrition estimates (JME). Aggregation is based on UNICEF, WHO, and the World Bank harmonized dataset (adjusted, comparable data) and methodology.; Linear mixed-effect model estimates; Estimates of overweight children are also from national survey data. Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues

The prevalence of obesity in the United States has risen gradually over the past decade. As of 2023, around ** percent of the population aged 18 years and older was obese. Obesity is a growing problem in many parts of the world, but is particularly troubling in the United States. Obesity in the United States The states with the highest prevalence of obesity are West Virginia, Mississippi, and Arkansas. As of 2023, a shocking ** percent of the population in West Virginia were obese. The percentage of adults aged 65 years and older who are obese has grown in recent years, compounding health issues that develop with age. Health impacts of obesity Obesity is linked to several negative health impacts including cardiovascular disease, diabetes, and certain types of cancer. Unsurprisingly, the prevalence of diagnosed diabetes has increased in the United States over the years. As of 2022, around *** percent of the population had been diagnosed with diabetes. Some of the most common types of cancers caused by obesity include breast cancer in postmenopausal women, colon and rectum cancer, and corpus and uterus cancer.

The prevalence of obesity in Latin America and the Caribbean is forecast to reach significant levels by 2035, with several countries attaining a prevalence of at least 40 percent among adults. In the Dominican Republic and Haiti, over half of the population could be affected. Even in countries with lower rates, at least a third of adults are expected to struggle with the condition.
Obesity and its impact on health
Obesity is associated with a range of diseases and medical conditions, including diabetes, hypertension, and cancer. In Brazil alone, an estimated 16 million people have been diagnosed with diabetes, resulting in yearly health expenses surpassing 40 billion U.S. dollars. If not treated, diabetes can result in additional health complications such as eye problems and cardiovascular conditions. Keeping a healthy diet Among other genetic, environmental, and socioeconomic causes, obesity is known to be strongly influenced by what people eat. In Latin America, the cost of a healthy diet has been constantly increasing in recent years, risking higher prevalence rates of the disease. Availability of unhealthy foods and a lack of time for preparing meals also discourage people from maintaining a healthy diet, resulting in the consumption of indulgent foods, snacks, and highly caloric beverages.

Obese Patient Care System Market Outlook

The global market size for Obese Patient Care Systems was estimated to be around USD 3.2 billion in 2023, with a Compound Annual Growth Rate (CAGR) of approximately 7.5% expected to drive the market to an estimated USD 6.4 billion by 2032. One of the key growth factors for this market includes the rising prevalence of obesity worldwide, which necessitates specialized equipment and systems to manage the unique healthcare needs of obese patients.

One of the primary growth factors for the obese patient care system market is the increasing prevalence of obesity globally. According to the World Health Organization (WHO), the number of obese individuals has tripled since 1975. As obesity is associated with various comorbidities such as diabetes, cardiovascular diseases, and musculoskeletal disorders, the need for specialized healthcare systems to cater to this demographic has become imperative. This trend is creating a sustained demand for obese patient care systems, ranging from beds and wheelchairs to specialized scales and lifts.

Technological advancements are another significant growth factor contributing to the expansion of the obese patient care system market. Innovations in medical devices, such as advanced bariatric beds with integrated monitoring systems and automated wheelchairs, are enhancing patient comfort and care efficiency. Manufacturers are increasingly focusing on developing user-friendly, durable, and multifunctional equipment that can withstand higher weights while ensuring safety. These technological improvements are making it easier for healthcare providers to deliver optimal care to obese patients, thereby driving market growth.

Government initiatives and policies aimed at combating obesity and improving healthcare infrastructure are also playing a crucial role in market expansion. Various countries are investing in healthcare facilities and programs to manage obesity more effectively. These initiatives often include funding for specialized equipment and training for healthcare providers, which in turn bolsters the demand for obese patient care systems. For instance, government grants and subsidies for hospitals to purchase bariatric equipment can significantly impact market growth.

In terms of regional outlook, North America is expected to dominate the obese patient care system market, followed by Europe and the Asia Pacific. The high prevalence of obesity in North America, particularly in the United States, along with well-established healthcare infrastructure, contributes to this dominance. Europe also shows significant potential due to rising obesity rates and increased healthcare spending. The Asia Pacific region, with its growing healthcare infrastructure and increasing awareness about obesity management, is anticipated to witness the highest growth rate during the forecast period.

Product Type Analysis

The product type segment of the obese patient care system market includes beds, lifts, scales, wheelchairs, commodes, and others. Each of these product types serves a unique role in managing and providing care for obese patients, making them indispensable in various healthcare settings. Among these, bariatric beds are one of the most crucial components, designed to accommodate higher weight capacities while providing comfort and safety. These beds often come with advanced features such as electric adjustments, integrated scales, and specialized mattresses to prevent pressure sores, making them highly sought after in hospitals and home care settings.

Lifts are another essential product type within the obese patient care system market. These devices are designed to assist in the safe and efficient transfer of obese patients, thereby reducing the risk of injury to both patients and healthcare providers. Modern lifts often come with advanced features like motorized operation, remote control, and multi-functional slings, enhancing their usability and effectiveness. The increasing focus on patient safety and comfort is driving the demand for advanced lift systems.

Scales specifically designed for obese patients are crucial for monitoring weight and managing overall health. These scales often have higher weight capacities and larger platforms compared to standard scales, ensuring accurate measurements for obese individuals. Some advanced models also offer digital readouts, wireless connectivity, and integration with electronic health records (EHR) systems, enhancing their utility in clinical settings. The growing emphasis on monitoring and managing obesity-related hea

In 2020, the countries with the highest share of men who were overweight or obese were Tonga, Samoa, and the United States. At that time, around 80 percent of men in Tonga aged 20 years and older were overweight or obese. Men were considered overweight if they had a body mass index (BMI) greater than or equal to 25kg/m², and obese if they had a BMI greater than or equal to 30 kg/m². Obesity among men Women tend to have higher rates of obesity than men, but worldwide rates have risen for both and are expected to climb in the coming years. In 2020, around 14 percent of men worldwide were obese, compared to 18 percent of women. The region of the Americas has the highest prevalence of obesity among men, but every region is expected to see increases in obesity among men over the next decade. In 2020, around 32 percent of men in the Americas were considered obese, with this rate expected to rise to 47 percent by 2035. Obesity raises the risk of developing a number of health conditions including high blood pressure, heart disease, and type 2 diabetes. Obesity in the United States In 2023, almost 33 percent of adults in the United States were considered obese. This was an increase from 27.4 percent in the year 2011. Women in the United States have slightly higher rates of obesity than men, with 33.5 percent of women obese in 2023, compared to 32.1 percent of men. The states with the highest obesity rates are West Virginia, Mississippi, and Arkansas. In 2023, an astounding 41 percent of adults in West Virginia were obese. Unhealthy eating behaviors and a lack of physical exercise are the main drivers of obesity.

Obesity Treatment Market Outlook

The global obesity treatment market size was valued at approximately USD 18.4 billion in 2023 and is projected to reach around USD 35.2 billion by 2032, reflecting a robust compound annual growth rate (CAGR) of 7.8% during the forecast period. This significant growth can be attributed to rising awareness about obesity-related health risks, increasing prevalence of obesity worldwide, and advancements in treatment technologies.

One of the primary growth factors driving the obesity treatment market is the escalating prevalence of obesity across the globe. According to the World Health Organization (WHO), obesity rates have nearly tripled since 1975, leading to a surge in demand for effective treatment options. The rising incidence of obesity is linked to sedentary lifestyles, unhealthy eating habits, and a lack of physical activity, which have become more prevalent in both developed and developing countries. This widespread increase in obesity rates is expected to continue driving the market’s expansion.

Another significant growth driver is the growing awareness of the health risks associated with obesity. Obesity is a major risk factor for numerous chronic diseases, including type 2 diabetes, cardiovascular diseases, and certain types of cancer. Governments and healthcare organizations worldwide are actively promoting obesity awareness and prevention campaigns, which are contributing to a heightened demand for treatment solutions. Additionally, the stigma surrounding obesity is gradually decreasing, encouraging more individuals to seek medical help for weight management.

Technological advancements and innovations in obesity treatment are also propelling market growth. The development of minimally invasive surgical procedures, new pharmacological treatments, and advanced medical devices has significantly improved the efficacy and safety of obesity treatments. For example, bariatric surgery techniques have evolved to become less invasive, reducing recovery times and complications. Similarly, novel medications are being developed to target obesity at a molecular level, offering more effective and personalized treatment options.

Regionally, North America dominates the obesity treatment market, driven by the high prevalence of obesity and well-established healthcare infrastructure. However, Asia Pacific is expected to witness the highest growth rate during the forecast period. This region is experiencing rapid economic growth, urbanization, and lifestyle changes, leading to an increase in obesity rates. Additionally, improving healthcare access and increasing awareness about obesity treatments are contributing to market growth in the Asia Pacific region.

Medication Analysis

The medication segment in the obesity treatment market encompasses a range of pharmaceutical products designed to aid in weight loss and management. These medications can be prescription-based or over-the-counter, and they work through various mechanisms, such as appetite suppression, fat absorption inhibition, and metabolic rate enhancement. The growing prevalence of obesity has led to increased research and development activities in this segment, resulting in the introduction of new and improved medications. Regulatory approvals for novel drugs are also contributing to market expansion, as they provide more effective treatment options for patients.

One key driver for the growth of the medication segment is the increasing preference for non-invasive treatment options. Many patients are reluctant to undergo surgical procedures due to the associated risks and recovery times. Medications offer a less invasive alternative, making them an attractive option for individuals seeking to manage their weight. Additionally, advancements in drug formulations and delivery methods have improved the efficacy and safety profiles of obesity medications, further boosting their adoption.

The availability of combination therapies is another factor driving the growth of the medication segment. Combining different pharmacological agents can enhance treatment outcomes by addressing multiple pathways involved in obesity. For example, some combination therapies may include appetite suppressants and fat absorption inhibitors, providing a more comprehensive approach to weight management. This trend towards combination therapies is expected to continue, offering more effective solutions for patients with complex needs.

Challenges in the medication segment include the potential for side effects and the need for l

The pediatric obesity management market is experiencing robust growth, driven by rising childhood obesity rates globally and increasing awareness of associated health risks. The market size in 2025 is estimated at $15 billion, exhibiting a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, projecting a market value exceeding $25 billion by 2033. This growth is fueled by several key factors: an increase in sedentary lifestyles among children, changing dietary habits with higher consumption of processed foods and sugary drinks, and a lack of access to adequate healthcare and nutritional education in many regions. Furthermore, advancements in obesity management treatments, including pharmaceuticals, bariatric surgery (where applicable and ethically sound), and technological solutions for weight management and monitoring, are further accelerating market expansion. Significant market segmentation exists based on treatment type (pharmaceutical interventions, behavioral therapies, surgical procedures, and digital health solutions), age group, and geographic region. North America currently holds the largest market share due to high obesity prevalence and advanced healthcare infrastructure. However, Asia-Pacific is expected to witness significant growth over the forecast period due to rising disposable incomes, increased awareness of obesity-related complications, and expanding healthcare sectors. Restraints to market growth include high treatment costs, limited access to specialized care in developing countries, and concerns regarding long-term efficacy and potential side effects of certain interventions. Nevertheless, the market's overall trajectory indicates strong potential for continued expansion, with a focus on developing affordable and accessible solutions tailored to diverse populations.

The global market for long-term treatment drugs for obesity is experiencing robust growth, driven by rising prevalence of obesity and related comorbidities like type 2 diabetes and cardiovascular disease. The market, estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 10% from 2025 to 2033, reaching an estimated value of $40 billion by 2033. This expansion is fueled by several key factors including increased awareness of obesity as a serious health condition, the development of more effective and tolerable medications like GLP-1 receptor agonists (Semaglutide and Liraglutide) and other novel therapeutics, and expanding access to healthcare in emerging markets. The segment comprising GLP-1 receptor agonists currently dominates the market due to their efficacy in weight loss and improved glycemic control, but other drug classes, including Orlistat and emerging novel agents, are expected to contribute significantly to market growth in the coming years. The hospital and clinic application segments represent the largest share of the market, reflecting the importance of these settings for both diagnosis and management of obesity. Geographic distribution of the market reflects higher prevalence rates in developed nations. North America and Europe currently hold substantial market shares, driven by high healthcare expenditure and greater awareness. However, significant growth opportunities exist in Asia-Pacific, particularly in countries like China and India, due to rapidly increasing rates of obesity and expanding healthcare infrastructure. Despite the strong growth trajectory, the market faces challenges, including high drug costs, potential side effects associated with certain medications, and the need for long-term lifestyle changes in conjunction with pharmacological interventions. Regulatory hurdles and the development of biosimilars also pose potential constraints on market growth in the long term. Major players such as Novo Nordisk, Roche, GSK, Vivus, Arena, and Orexigen are actively involved in research, development, and commercialization, driving innovation and competition within the market.

Total number of obese pregnant women,rate of obesity among female for the 20 high obesity burden countries.

S1 Table. Prevalence of HPF within Food Main Categories across Countries. S2 Table. Summary of the Prevalence of HPF across Countries.S3 Table. Logistic regression results for the HPF prevalence compared to United States. S4 Table. Logistic regression results for the FSOD prevalence compared to United States. S5 Table. Logistic regression results for the FS prevalence compared to United States. S6 Table. Logistic regression results for the CSOD prevalence compared to United States. S7 Table. Descriptive Statistics of Nutritional Compositions of FSOD across Countries.S8 Table. Descriptive Statistics of Nutritional Compositions of FS across Countries. S9 Table. Descriptive Statistics of Nutritional Compositions of CSOD across Countries. S10 Table. Ordered Beta Regression Results for nutritional compositions of FSOD across countries compared to United States.S11 Table. Ordered Beta Regression Results for nutritional compositions of FS across countries compared to United States. S12 Table. Ordered Beta Regression Results for nutritional compositions of CSOD across countries compared to United States. S13 Table. Distinct and Overlapping percentage of HPF and UPF across countries. (ZIP)

The global market for beds designed for obese patients is experiencing robust growth, driven by the rising prevalence of obesity worldwide and an increasing demand for specialized healthcare solutions. The market, currently valued at approximately $500 million in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033. This growth is fueled by several key factors. Firstly, the escalating rates of obesity and related health issues, such as diabetes and cardiovascular disease, necessitate the use of specialized beds that can accommodate larger individuals and reduce the risk of pressure ulcers and other complications. Secondly, technological advancements in bed design are leading to the introduction of more comfortable, durable, and adjustable beds that cater to the specific needs of obese patients. Hospitals and healthcare facilities are increasingly adopting these beds to improve patient care and reduce healthcare costs associated with complications related to obesity. Finally, growing awareness among consumers regarding the benefits of specialized beds is driving demand in the homecare segment. This is supported by an increase in home healthcare services and a growing preference for receiving care in a familiar and comfortable setting. The market segmentation reveals significant opportunities. The 300-400KG capacity segment currently holds the largest market share, driven by its suitability for a broad range of patient weights. However, the 400-500KG segment is anticipated to witness faster growth due to the increasing number of severely obese individuals. Geographically, North America currently dominates the market, owing to high obesity rates and well-established healthcare infrastructure. However, Asia-Pacific, especially China and India, is expected to show substantial growth in the coming years due to rising obesity levels and increasing healthcare expenditure in these regions. Key restraints on market growth include high initial investment costs associated with purchasing specialized beds and the limited availability of these beds in some regions, particularly in developing countries. However, ongoing technological innovations, coupled with government initiatives to improve healthcare infrastructure and address obesity-related issues, are expected to mitigate these limitations and propel the market's growth trajectory. Leading manufacturers, such as Stryker, ArjoHuntleigh, and Invacare, are actively engaged in product development and market expansion strategies to capitalize on the burgeoning demand for beds for obese patients.

The global obesity treatment surgery devices market is experiencing robust growth, driven by the rising prevalence of obesity and related comorbidities like type 2 diabetes and cardiovascular disease. The market, estimated at $2.5 billion in 2025, is projected to expand significantly over the forecast period (2025-2033), fueled by a Compound Annual Growth Rate (CAGR) of approximately 8%. This growth is attributed to several factors, including technological advancements leading to less invasive procedures, improved patient outcomes, and increased awareness of bariatric surgery options. The market is segmented by application (hospitals, clinics, beauty institutions, others) and device type (Roux-En-Y Gastric Bypass, Sleeve Gastrectomy, Adjustable Gastric Banding, Biliopancreatic Diversion with Duodenal Switch, Gastrotropic Solution, others), with Roux-En-Y Gastric Bypass and Sleeve Gastrectomy currently holding the largest market shares due to their widespread adoption and established efficacy. North America and Europe currently dominate the market, owing to higher adoption rates and advanced healthcare infrastructure. However, Asia-Pacific is expected to witness the fastest growth in the coming years, driven by increasing disposable incomes, rising obesity rates, and expanding healthcare sectors in countries like India and China. The market faces certain restraints, including the high cost of procedures, potential complications associated with surgery, and the availability of alternative weight-loss methods. Nevertheless, the long-term outlook remains positive, with continued innovation in minimally invasive surgical techniques and the development of new devices expected to further stimulate market expansion. Leading players like Allergan, Apollo Endosurgery, Medtronic, and Intuitive Surgical are actively engaged in research and development to enhance existing technologies and introduce innovative products. Competitive strategies such as mergers and acquisitions, strategic partnerships, and product launches are shaping the market landscape. The increasing focus on improving patient outcomes through personalized treatment plans and enhanced post-operative care is contributing to the market's growth trajectory. The rising adoption of telehealth and remote patient monitoring technologies is also expected to facilitate better patient management and improve the overall efficiency of bariatric surgery programs. Future growth will depend on factors such as continued technological advancements, regulatory approvals for new devices, and expanding insurance coverage for bariatric surgery. The market's trajectory indicates significant potential for growth, especially in developing economies with rising obesity rates and increasing access to advanced healthcare facilities.

About a fifth of Hispanic high school students in the United States were overweight between 2016 and 2017, making it the ethnic group with the highest percentage of overweight high school students. Female obesity rates were considerably higher than those of male students for the black and Hispanic groups during the measured period.

Overweight and obese U.S. adults

U.S. overweight rates in adults differed slightly from those of U.S. high school students in 2017. That year, the African American population had the highest overweight and obesity rates of any race or ethnicity, closely followed by American Indians/Alaska Natives and Hispanics. Over 73 percent of all African American adults in the country were either overweight or obese. In 2018, the highest rates of obesity among African Americans could be found in states, such as Mississippi, Arkansas, and Tennessee.

Overweight youth worldwide

Many children and adolescents in other countries, such as New Zealand, Greece, and Italy, also struggle with overweight and obesity. In New Zealand, for example, over forty percent of boys and girls, up to age 19, were overweight or obese in 2016. In the same year, less than ten percent of Indian children and teenagers were overweight.

The global weight management market, valued at $247.68 billion in 2025, is projected to experience robust growth, driven by a rising prevalence of obesity and related health issues worldwide. A compound annual growth rate (CAGR) of 6.9% from 2025 to 2033 indicates a significant expansion of this market, reaching an estimated $430 billion by 2033. Key drivers include increasing health consciousness, rising disposable incomes, particularly in developing economies, and the proliferation of innovative weight loss solutions. These solutions encompass a wide range of products and services, including weight-loss diets (such as Atkins and Jenny Craig), fitness equipment (from established brands like ICON Health & Fitness and Technogym to smaller players), surgical and other medical interventions, fitness centers (e.g., Planet Fitness, Gold's Gym), and specialized weight loss programs. Market segmentation reveals significant demand across both men and women, although specific marketing strategies might need tailoring to address the unique needs and preferences of each demographic. Geographic distribution shows strong growth potential across diverse regions, with North America and Europe currently holding substantial market share but significant opportunities emerging in rapidly developing economies in Asia-Pacific and other regions. Challenges include maintaining long-term weight loss success, managing customer expectations, and navigating varying regulations across different countries. The competitive landscape is characterized by a mix of established multinational corporations like Herbalife and Weight Watchers, alongside smaller, specialized players catering to niche markets. Competition is intense, driven by product innovation, brand recognition, marketing strategies, and distribution channels. The market's future trajectory hinges on continuous innovation in weight management technologies and programs, alongside effective strategies to address the rising prevalence of obesity and associated health concerns while adapting to evolving consumer preferences and technological advancements. The focus will shift increasingly towards personalized, sustainable solutions, incorporating technological advancements and digital health platforms for improved efficacy and engagement.

countries Main continent America. name, long name, population (source), population, constitutional form, drives on, head of state authority, Main continent, number of airports, Airports - with paved runways, Airports - with unpaved runways, Area, Birth rate, calling code, Children under the age of 5 years underweight, Current Account Balance, Death rate, Debt - external, Economic aid donor, Electricity consumption, Electricity consumption per capita, Electricity exports, Electricity imports, Electricity production, Exports, GDP - per capita (PPP), GDP (purchasing power parity), GDP real growth rate, Gross national income, Human Development Index, Health expenditures, Heliports, HIV AIDS adult prevalence rate, HIV AIDS deaths, HIV AIDS people living with HIV AIDS, Hospital bed density, capital city, Currency, Imports, Industrial production growth rate, Infant mortality rate, Inflation rate consumer prices, Internet hosts, internet tld, Internet users, Investment (gross fixed), iso 3166 code, ISO CODE, Labor force, Life expectancy at birth, Literacy, Manpower available for military service, Manpower fit for military service, Manpower reaching militarily age annually, is democracy, Market value of publicly traded shares, Maternal mortality rate, Merchant marine, Military expenditures percent of GDP, Natural gas consumption, Natural gas consumption per capita, Natural gas exports, Natural gas imports, Natural gas production, Natural gas proved reserves, Net migration rate, Obesity adult prevalence rate, Oil consumption, Oil consumption per capita, Oil exports, Oil imports, Oil production, Oil proved reserves, Physicians density, Population below poverty line, Population census, Population density, Population estimate, Population growth rate, Public debt, Railways, Reserves of foreign exchange and gold, Roadways, Stock of direct foreign investment abroad, Stock of direct foreign investment at home, Telephones main lines in use, Telephones main lines in use per capita, Telephones mobile cellular, Telephones mobile cellular per capita, Total fertility rate, Unemployment rate, Unemployment, youth ages 15-24, Waterways, valley, helicopter, canyon, artillery, crater, religion, continent, border, Plateau, marsh, Demonym